myeloproliferative disorders
Showing 1 - 25 of >10,000
Epidemiological and Clinical-pathological Factors of
Completed
- Myeloproliferative Neoplasm
- +4 more
-
Guayaquil, Guayas, EcuadorSociedad de Lucha Contra el Cáncer
Apr 25, 2023
Myeloproliferative Disorders, Essential Thrombocythemia, Tumors Trial (JNJ-88549968)
Not yet recruiting
- Myeloproliferative Disorders
- +3 more
- (no location specified)
Nov 21, 2023
Myeloproliferative Disorders, Leukemia Trial in Boston (Cardiac Lifestyle Program)
Not yet recruiting
- Myeloproliferative Disorders
- Leukemia
- Cardiac Lifestyle Program
-
Boston, Massachusetts
- +2 more
May 1, 2023
Epigenetic Age on Clinic-biological Presentation and Prognosis
Not yet recruiting
- Myeloproliferative Neoplasm
- Assessment of the epigenetic age
-
Bordeaux, FranceCHU de Bordeaux, service Hématologie Biologique
Aug 28, 2023
Carotid Plaque Burden in Philadelphia Negative
Recruiting
- Myeloproliferative Neoplasm
-
Sohag, EgyptFaculty of Medicine
Aug 14, 2023
Action of Interferon in Treatment of Myeloproliferative
Recruiting
- Myeloproliferative Neoplasm
-
Villejuif, Ile De France, FranceInserm U1287
Apr 28, 2023
Myeloproliferative Tumor, Polycythemia Vera, Essential Thrombocythemia Trial in Hong Kong
Recruiting
- Myeloproliferative Neoplasm
- +7 more
-
Hong Kong, Hong KongDepartment of Medicine, Queen Mary Hospital
May 21, 2023
Acute Myeloid Leukemia, Leukemia, Leukemia, Myeloid Trial in Boston (Cytokine Induced Memory-like Natural Killer Cells,
Not yet recruiting
- Acute Myeloid Leukemia
- +5 more
- Cytokine Induced Memory-like Natural Killer Cells
- Interleukin-2
-
Boston, Massachusetts
- +1 more
Nov 14, 2023
Healthy Volunteers of Fanconi Anemia, Myeloproliferative
Completed
- Chronic Myeloproliferative Disorders
- +3 more
- microarray analysis
- +8 more
-
Portland, OregonKnight Cancer Institute at Oregon Health and Science University
Jun 30, 2022
Myeloproliferative Tumor, Secondary Leukemia Trial (Multiomic characterization, In vitro drug screening)
Not yet recruiting
- Myeloproliferative Neoplasm
- Secondary Leukemia
- Multiomic characterization
- In vitro drug screening
- (no location specified)
Aug 28, 2023
Immune System Diseases, Autoimmune Diseases, Inflammation Trial (observational cohort study)
Not yet recruiting
- Immune System Diseases
- +15 more
- observational cohort study
- (no location specified)
Jul 23, 2023
Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs
Not yet recruiting
- Myeloproliferative Neoplasms (MPNs)
- Reverse transcription-quantitative polymerase chain reaction (RT-qPCR)
- (no location specified)
Mar 24, 2023
Myeloproliferative Tumor, Optical Genome Mapping, Cytogenetics Trial in Amiens (Blood sample)
Recruiting
- Myeloproliferative Neoplasm
- +4 more
- Blood sample
-
Amiens, Picardie, FranceCentre Hospitalier Universitaire d'Amiens
Jan 27, 2023
Myeloproliferative Tumor Trial in Tampa (Fedratinib Pill)
Recruiting
- Myeloproliferative Neoplasm
- Fedratinib Pill
-
Tampa, FloridaMoffitt Cancer Center
Nov 28, 2022
Pathogenesis of Hematologic Malignancies
Enrolling by invitation
- Acute Leukemia
- +3 more
- blood draw, bone marrow procedure, or tissue biopsy
-
Portland, OregonOHSU Knight Cancer Institute
Sep 9, 2022
Myeloproliferative Tumor, MPN, Essential Thrombocythemia Trial in Orange (N-Acetylcysteine)
Active, not recruiting
- Myeloproliferative Neoplasm
- +4 more
-
Orange, CaliforniaChao Family Comprehensive Cancer Center, University of Californi
Jan 6, 2023
Myelofibrosis (PMF), Post Essential Thrombocythemia Myelofibrosis (ET-MF), Post Polycythemia Vera Related Myelofibrosis (PV-MF)
Not yet recruiting
- Myelofibrosis (PMF)
- +2 more
-
New York, New YorkRuttenberg Treatment Center
Apr 18, 2023
Myelodysplastic/Myeloproliferative Tumor, Steroid Refractory GVHD, Allogeneic Hematopoietic Cell Transplant Trial in Toronto
Completed
- Myelodysplastic/Myeloproliferative Neoplasm
- +2 more
- Decidual stromal cells (DSC)
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Jan 8, 2023
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Atypical Chronic Myeloid
Active, not recruiting
- Acute Myeloid Leukemia
- +9 more
- Carboplatin
- +3 more
-
Los Angeles, California
- +5 more
Jan 27, 2023
Bone Marrow Fibrosis, Myeloproliferative Tumor Trial in Cleveland (Captopril)
Not yet recruiting
- Bone Marrow Fibrosis
- Myeloproliferative Neoplasm
-
Cleveland, OhioCleveland Clinic, Case Comprehensive Cancer Center
Jan 30, 2023
Myeloid Malignancy, Acute Myeloid Leukemia, MDS Trial in Rochester (Telehealth Serious Illness Care Program, Education Control)
Not yet recruiting
- Myeloid Malignancy
- +4 more
- Telehealth Serious Illness Care Program
- Education Control
-
Rochester, New YorkUniversity of Rochester
May 24, 2023
Monocytes Sub-populations in Thrombosis Associated With
Recruiting
- Myeloproliferative Neoplasm
- 1 additional tube of blood
-
Bordeaux, France
- +4 more
Nov 30, 2022